Biotechnology
4 articles

Biotech & Healthtech
AI in early drug discovery: Advantages and challenges
AI-discovered molecules have an 80-90% success rate in Phase I clinical trials, a figure substantially higher than historic industry averages, according to PubMed and Nature .
Mateo Rossi·July 19, 2026

Biotech & Healthtech
What is CRISPR Gene Editing and Why is it Revolutionizing Medicine?
In 2020, a CRISPR treatment was injected directly into human patients for the first time, marking a pivotal moment in the quest to rewrite the human genome.
Mateo Rossi·June 19, 2026

Biotech & Healthtech
Personalized Medicine: Genetic Profiling's 2026 Challenges
Despite the promise of tailoring treatments to individual genetic profiles, simulations based on two clinical trials did not provide evidence of benefit from personalization, according to research pub
Mateo Rossi·June 9, 2026

Biotech & Healthtech
What is AI in Disease Diagnosis and Why Does it Matter?
In a growing number of cases, AI algorithms are diagnosing diseases from imaging scans with higher accuracy and speed than human radiologists, according to the cdc .
Mateo Rossi·May 29, 2026